Status:
COMPLETED
Investigational Drug Versus an Approved Drug in Patients With Rheumatoid Arthritis (0663-072)
Lead Sponsor:
Organon and Co
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
50+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to evaluate the long-term safety of an investigational drug versus an approved drug for the relief of pain in patients with rheumatoid arthritis.
Detailed Description
The duration of treatment is 12 months.
Eligibility Criteria
Inclusion
- Males and females 50 years or older with rheumatoid arthritis.
Exclusion
- History of gastrointestinal malabsorption or inflammatory bowel disease
- History of heart problems such as: congestive heart failure (CHF), heart attack or high blood pressure.
Key Trial Info
Start Date :
February 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2005
Estimated Enrollment :
4086 Patients enrolled
Trial Details
Trial ID
NCT00092742
Start Date
February 1 2003
End Date
December 1 2005
Last Update
February 16 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.